You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 22, 2024

Details for New Drug Application (NDA): 022417

✉ Email this page to a colleague

« Back to Dashboard

NDA 022417 describes NORVIR, which is a drug marketed by Abbott and Abbvie and is included in five NDAs. It is available from one supplier. Additional details are available on the NORVIR profile page.

The generic ingredient in NORVIR is ritonavir. There are twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ritonavir profile page.
Summary for 022417
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 022417
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORVIR ritonavir TABLET;ORAL 022417 NDA AbbVie Inc. 0074-2340 0074-2340-30 30 TABLET, FILM COATED in 1 BOTTLE (0074-2340-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Feb 10, 2010TE:ABRLD:Yes

Expired US Patents for NDA 022417

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie NORVIR ritonavir TABLET;ORAL 022417-001 Feb 10, 2010 ⤷  Sign Up ⤷  Sign Up
Abbvie NORVIR ritonavir TABLET;ORAL 022417-001 Feb 10, 2010 ⤷  Sign Up ⤷  Sign Up
Abbvie NORVIR ritonavir TABLET;ORAL 022417-001 Feb 10, 2010 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.